Evolutionary Heterogeneity of High Grade Glioma
Evolutionary Heterogeneity of High Grade Glioma
批准号:
9981692
负责人:
Erik Ladewig
金额:
$9.59万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-01 至 2022-08-31
关键词:
AddressAftercareAgeAlgorithmsBiological MarkersBiologyBiopsyBrainBrain NeoplasmsCellsClinicalClinical DataCollectionDNADNA Sequence AlterationDataData AnalysesDevelopmentDiseaseEvolutionFutureGeneticGenomic approachGenomicsGlioblastomaGliomaHeterogeneityHumanHuman Cell LineIndividualInternationalLaboratoriesLeadLiquid substanceLongitudinal cohortMalignant NeoplasmsManuscriptsMathematicsMethodsModelingMutationNeoplasm MetastasisPathway interactionsPatientsPatternPharmaceutical PreparationsPharmacotherapyPlant RootsRNARecording of previous eventsRecurrenceRegimenRelapseResearchResearch Project GrantsResistanceResourcesRouteSamplingSolidSolid NeoplasmStatistical MethodsStatistical ModelsTechniquesTestingThe Cancer Genome AtlasTherapeuticTimeTransforming Growth Factor betaTreesValidationWorkanalysis pipelinebasecancer genomeclinically relevantcohortcomputer frameworkdriving forceexhaustionexomegenomic datahuman datainsightinterestnext generation sequencingoutcome forecastpersonalized medicinereconstructionstatisticstargeted treatmenttherapeutic targettranscriptomicstumortumor heterogeneityuncontrolled cell growth
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Cancer is the result of an orchestrated set of genomic alterations that conspire to drive
uncontrolled cell growth. Dissecting temporal and spatial association of these alterations into
varying time points will provide milestones into initiation, progression, metastasis and/or
resistance to certain therapeutic regimens. Elucidating these milestones could provide invaluable
biomarkers in the context of different stages for treatments and would help to tailor personalized
therapies based on genomic information. We will develop a model to infer a possible ordering of
alterations from longitudinal, multi-region, transcriptomic and single cell data by first discerning
the totality of significant alterations and most likely contributors to progression using a rigorous
genomic approach. Next we will infer potential evolutionary moves of each patient using
sequential samples with a statistical approach rooted in evolutionary biology. Third we will
construct an evolutionary network for the cohort of patients that will delineate and order significant
routes of genomic alteration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evolutionary Heterogeneity of High Grade Glioma
-
批准号:10249322
-
项目类别:
-
资助金额:$10.07万
-
财政年份:2018
-
负责人:Erik Ladewig
-
依托单位:
Evolutionary Heterogeneity of High Grade Glioma
-
批准号:9355606
-
项目类别:
-
资助金额:$4.11万
-
财政年份:2016
-
负责人:Erik Ladewig
-
依托单位:
海外基金